BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opko Health, Inc. 



Miami  Florida    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Diagnostics






 Company News
Neovasc Inc. (NVC), An Opko Health, Inc. Investee, Receives FDA Conditional Approval To Initiate TIARA-I Trial In U.S.: A Multinational, Multicenter Early Feasibility Trial Of The Tiaratm Transcatheter Mitral Valve 10/9/2014 11:04:18 AM
Opko Health, Inc. Supports National Prostate Cancer Council Legislation 9/29/2014 12:53:03 PM
Opko Health, Inc.'s Second Rayaldee Phase 3 Trial Meets Primary Endpoints 9/23/2014 10:57:13 AM
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Opko Health, Inc. Release: Rayaldee Phase 3 Trial Meets Primary Endpoints 8/12/2014 9:30:11 AM
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014 8:36:37 AM
Opko Health, Inc. To Announce Top Line RAYALDEE Results And Second Quarter 2014 Financial Results On August 11, 2014 8/7/2014 10:29:35 AM
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014 10:06:07 AM
Opko Health, Inc.'s Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations In Europe 7/9/2014 11:33:50 AM
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014 10:22:05 AM
12345678910...